DK0838223T3 - Hjerneødeminhibitor - Google Patents
HjerneødeminhibitorInfo
- Publication number
- DK0838223T3 DK0838223T3 DK96919984T DK96919984T DK0838223T3 DK 0838223 T3 DK0838223 T3 DK 0838223T3 DK 96919984 T DK96919984 T DK 96919984T DK 96919984 T DK96919984 T DK 96919984T DK 0838223 T3 DK0838223 T3 DK 0838223T3
- Authority
- DK
- Denmark
- Prior art keywords
- endothelin antagonist
- treating
- brain edemas
- edemas
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16006095 | 1995-06-02 | ||
PCT/JP1996/001438 WO1996038173A1 (fr) | 1995-06-02 | 1996-05-29 | Inhibiteur de l'oedeme cerebral |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0838223T3 true DK0838223T3 (da) | 2003-11-17 |
Family
ID=15707042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96919984T DK0838223T3 (da) | 1995-06-02 | 1996-05-29 | Hjerneødeminhibitor |
Country Status (16)
Country | Link |
---|---|
US (1) | US5945448A (fr) |
EP (1) | EP0838223B1 (fr) |
JP (1) | JP4011114B2 (fr) |
KR (1) | KR100399797B1 (fr) |
CN (1) | CN1083261C (fr) |
AT (1) | ATE245447T1 (fr) |
AU (1) | AU700182B2 (fr) |
BR (1) | BR9608413A (fr) |
CA (1) | CA2218028C (fr) |
DE (1) | DE69629195T2 (fr) |
DK (1) | DK0838223T3 (fr) |
ES (1) | ES2202449T3 (fr) |
PT (1) | PT838223E (fr) |
TR (1) | TR199701497T1 (fr) |
TW (1) | TW460286B (fr) |
WO (1) | WO1996038173A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6482857B1 (en) | 1998-07-17 | 2002-11-19 | The University Of Texas Southwestern Medical Center | Compositions which contain triterpenes for regulating hair growth |
US6124362A (en) * | 1998-07-17 | 2000-09-26 | The Procter & Gamble Company | Method for regulating hair growth |
JP2007217438A (ja) * | 2001-07-17 | 2007-08-30 | Shionogi & Co Ltd | 注射用医薬製剤 |
TWI232102B (en) * | 2001-07-17 | 2005-05-11 | Shionogi & Co | A pharmaceutical formulation for injection |
EP2298316A1 (fr) | 2002-08-28 | 2011-03-23 | Harbor BioSciences, Inc. | Procedes de traitement therapeutique |
US7861479B2 (en) | 2005-01-14 | 2011-01-04 | Airlite Plastics, Co. | Insulated foam panel forms |
WO2007106494A2 (fr) * | 2006-03-13 | 2007-09-20 | Encysive Pharmaceuticals, Inc. | Procedes et compositions pour le traitement d'une insuffisance cardiaque diastolique |
US8080549B2 (en) | 2007-01-12 | 2011-12-20 | Concert Pharmaceuticals, Inc. | Endothelin receptor antagonists |
WO2008088727A2 (fr) | 2007-01-12 | 2008-07-24 | Concert Pharmaceuticals, Inc. | Antagonistes du récepteur de l'endothéline |
CA2793668A1 (fr) | 2011-10-31 | 2013-04-30 | Bradley J. Crosby | Appareil et methode de construction de structures a l'aide de formes de beton isolees |
US8887465B2 (en) | 2012-01-13 | 2014-11-18 | Airlite Plastics Co. | Apparatus and method for construction of structures utilizing insulated concrete forms |
USD713975S1 (en) | 2012-07-30 | 2014-09-23 | Airlite Plastics Co. | Insulative insert for insulated concrete form |
US10787827B2 (en) | 2016-11-14 | 2020-09-29 | Airlite Plastics Co. | Concrete form with removable sidewall |
US11155995B2 (en) | 2018-11-19 | 2021-10-26 | Airlite Plastics Co. | Concrete form with removable sidewall |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE164588T1 (de) * | 1991-01-29 | 1998-04-15 | Shionogi & Co | Triterpenderivat |
ES2094622T3 (es) * | 1993-06-11 | 1997-01-16 | Shionogi & Co | Derivados triterpenos y antagonistas del receptor de endotelina que los contiene. |
US5599811A (en) * | 1995-02-21 | 1997-02-04 | Warner-Lambert Company | Benzothiazine dioxides as endothelin antagonists |
-
1996
- 1996-05-29 AT AT96919984T patent/ATE245447T1/de not_active IP Right Cessation
- 1996-05-29 CA CA2218028A patent/CA2218028C/fr not_active Expired - Fee Related
- 1996-05-29 KR KR1019970707867A patent/KR100399797B1/ko not_active IP Right Cessation
- 1996-05-29 PT PT96919984T patent/PT838223E/pt unknown
- 1996-05-29 US US08/930,827 patent/US5945448A/en not_active Expired - Lifetime
- 1996-05-29 EP EP96919984A patent/EP0838223B1/fr not_active Expired - Lifetime
- 1996-05-29 AU AU58440/96A patent/AU700182B2/en not_active Ceased
- 1996-05-29 DE DE69629195T patent/DE69629195T2/de not_active Expired - Lifetime
- 1996-05-29 JP JP53636696A patent/JP4011114B2/ja not_active Expired - Fee Related
- 1996-05-29 DK DK96919984T patent/DK0838223T3/da active
- 1996-05-29 CN CN96194363A patent/CN1083261C/zh not_active Expired - Fee Related
- 1996-05-29 BR BR9608413A patent/BR9608413A/pt not_active Application Discontinuation
- 1996-05-29 ES ES96919984T patent/ES2202449T3/es not_active Expired - Lifetime
- 1996-05-29 WO PCT/JP1996/001438 patent/WO1996038173A1/fr active IP Right Grant
- 1996-05-29 TR TR97/01497T patent/TR199701497T1/xx unknown
- 1996-06-01 TW TW085106558A patent/TW460286B/zh active
Also Published As
Publication number | Publication date |
---|---|
ATE245447T1 (de) | 2003-08-15 |
PT838223E (pt) | 2003-12-31 |
CN1186441A (zh) | 1998-07-01 |
WO1996038173A1 (fr) | 1996-12-05 |
EP0838223A1 (fr) | 1998-04-29 |
MX9708920A (es) | 1998-03-31 |
CN1083261C (zh) | 2002-04-24 |
AU5844096A (en) | 1996-12-18 |
KR100399797B1 (ko) | 2004-04-13 |
DE69629195T2 (de) | 2004-05-06 |
CA2218028C (fr) | 2010-07-06 |
JP4011114B2 (ja) | 2007-11-21 |
DE69629195D1 (de) | 2003-08-28 |
BR9608413A (pt) | 1998-12-29 |
CA2218028A1 (fr) | 1996-12-05 |
TR199701497T1 (xx) | 1998-06-22 |
US5945448A (en) | 1999-08-31 |
EP0838223A4 (fr) | 2001-04-25 |
KR19990008341A (ko) | 1999-01-25 |
ES2202449T3 (es) | 2004-04-01 |
AU700182B2 (en) | 1998-12-24 |
EP0838223B1 (fr) | 2003-07-23 |
TW460286B (en) | 2001-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE195117T1 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
DK0838223T3 (da) | Hjerneødeminhibitor | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
DE69413237T2 (de) | Plättchenaggregationsinhibitoren | |
RU94036772A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза | |
RU94044454A (ru) | Ингибитор аутоимунных заболеваний | |
BR0113389A (pt) | Compostos que inibem a atividade do fator xa | |
RU94044356A (ru) | Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с | |
ATE386523T1 (de) | Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes | |
ES2110115T3 (es) | Inhibidores de la agregacion de plaquetas. | |
DK0804418T3 (da) | Platelataggregationshæmmere | |
DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
ATE160143T1 (de) | 2-substituierte morpholin- und thiomorpholinderivate als gaba-b antagonisten | |
PL313037A1 (en) | Phenoxphenylocyclopententenylohydroxyureas | |
ES2140531T3 (es) | Inhibidor de la interleucina-1. | |
AU2101792A (en) | Methanoanthracene D2 dopamine antagonists | |
WO2024075070A3 (fr) | Nouveaux composés hétérocyclyle bicycliques et leur utilisation |